Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer’s disease in a cross-sectional multi-cohort study

QR Code

Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer’s disease in a cross-sectional multi-cohort study

Abstract Normative modelling is an emerging method for quantifying how individuals deviate from the healthy populational pattern. Several machine learning models have been implemented to develop normative models to investigate brain disorders, including regression, support vector machines and Gaussi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Walter H. L. Pinaya, Cristina Scarpazza, Rafael Garcia-Dias, Sandra Vieira, Lea Baecker, Pedro F da Costa, Alberto Redolfi, Giovanni B. Frisoni, Michela Pievani, Vince D. Calhoun, João R. Sato, Andrea Mechelli
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/232c67a78bc8428fb037c3b63039cf5c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
par: Xiong Jiang, et autres
Publié: (2021)

A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
par: Leigh A Johnson, et autres
Publié: (2013)

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease
par: Fujimoto N, et autres
Publié: (2019)

Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
par: Paul Loyd Wheeler, et autres
Publié: (2021)

Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease.
par: Eun Hyun Seo, et autres
Publié: (2013)

Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease
par: Xiao-Yan Ge, et autres
Publié: (2021)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
par: Wenjuan Rui, et autres
Publié: (2021)

Effects of Meditation on Structural Changes of the Brain in Patients With Mild Cognitive Impairment or Alzheimer’s Disease Dementia
par: Madhukar Dwivedi, et autres
Publié: (2021)

Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
par: Ozkan S, et autres
Publié: (2013)

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
par: Han Li, et autres
Publié: (2014)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
par: Sacco G, et autres
Publié: (2012)

Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
par: Shizuo Hatashita, et autres
Publié: (2013)

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
par: Eugenia Trushina, et autres
Publié: (2013)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
par: Dongwha Sohn, et autres
Publié: (2018)

Donepezil for mild cognitive impairment in Parkinson’s disease
par: Kyoungwon Baik, et autres
Publié: (2021)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
par: Samtani MN, et autres
Publié: (2014)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
par: Harris P, et autres
Publié: (2015)

Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease
par: Li W, et autres
Publié: (2016)

Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.
par: Gretel Sanabria-Diaz, et autres
Publié: (2013)

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
par: Moeko Noguchi-Shinohara, et autres
Publié: (2021)

Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
par: Jingwen Hui, et autres
Publié: (2021)

Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
par: Diyang Lyu, et autres
Publié: (2021)

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer’s disease
par: Moeko Noguchi-Shinohara, et autres
Publié: (2021)

Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
par: Albert Dayor Piersson, et autres
Publié: (2021)

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
par: Sebastian Palmqvist, et autres
Publié: (2012)

Relationship between Amyloid-β Deposition and the Coupling between Structural and Functional Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
par: Hui Zhang, et autres
Publié: (2021)

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
par: Wei-Ju Lee, et autres
Publié: (2018)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
par: Martina Laczó, et autres
Publié: (2021)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
par: Florinda Ferreri, et autres
Publié: (2021)

Is Non-invasive brain stimulation an effective tool for cognitive enhancement in Alzheimer’s disease and mild cognitive impairment? Results from the meta-analysis
par: Patrik Šimko, et autres
Publié: (2021)

Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
par: Yumi Umeda-Kameyama, et autres
Publié: (2017)

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study
par: Guerriero F, et autres
Publié: (2015)

Is the left uncinate fasciculus associated with verbal fluency decline in mild Alzheimer's disease?
par: Kljajevic Vanja, et autres
Publié: (2016)

Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer’s disease
par: Pooja Jadiya, et autres
Publié: (2019)

Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
par: Erika J Lampert, et autres
Publié: (2013)

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial
par: Zhao J, et autres
Publié: (2018)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
par: Celina S. Liu, et autres
Publié: (2021)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
par: Ferris SH, et autres
Publié: (2013)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
par: Maynard SD, et autres
Publié: (2013)